This week Bobbi Conner talks with Dr. Besim Ogretmen about the development of a clinical research trial to see if T cells from patients who have recovered from COVID-19 can be used to help critically ill COVID-19 patients recover. Dr. Ogretmen is the Director for the Center of Biomedical Research Excellence in Lipidomics and Pathobiology at Hollings Cancer Center at MUSC.
The latest South Carolina Public Radio News reports on the spread of the coronavirus and efforts to fight it.
T Cell & COVID-19 Research
MUSC
